GPR55 and neoplasm: The results from studies utilizing PANC-1 cell cultures are consistent with the tumor-derived data and indicate that the bifunctional properties of (R,S′)-MNF as GPR55 antagonist and β2-AR-biased agonist both contribute to the observed antitumor effects (Fig. 6).